-Hideo Kunitoh Researcher Activity Profile

Research Author Detailed Information 

Hideo Kunitoh Publication Rate By Year

Hideo Kunitoh has published 1 paper(s) in 2002, 1 paper(s) in 2006, 16 paper(s) in 2007, 4 paper(s) in 2008, for a total of 22 research publications in total.

Hideo H Kunitoh Author Information

LAST NAME: kunitoh

FIRST NAME: Hideo

INITIALS: h

AFFILIATION:

Papers

Hideo Kunitoh's Publication Record

1. Concurrent chemoradiotherapy for limited-disease small cell lung cancer in elderly patients aged 75 years or older. Year Published: 2007
Division of Internal Medicine and Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan.
2. Phase I study of cisplatin analogue nedaplatin, paclitaxel, and thoracic radiotherapy for unresectable stage III non-small cell lung cancer. Year Published: 2007
Division of Internal Medicine and Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan. isekine@ncc.go.jp
3. Localization of a human lung adenocarcinoma susceptibility locus, possibly syntenic to the mouse Pas1 locus, in the vicinity of the D12S1034 locus on chromosome 12p11.2-p12.1. Year Published: 2002
Biology Division, National Cancer Center Research Institute, 1-1,Tsukiji 5-chome, Chuo-ku, Tokyo 104-0045, Japan.
4. Detection of epidermal growth factor receptor mutations in serum as a predictor of the response to gefitinib in patients with non-small-cell lung cancer. Year Published: 2006
Shien-Lab, Medical Oncology, National Cancer Center Hospital, Tokyo, Japan.
5. Prognostic factors for malignant pericardial effusion treated by pericardial drainage in solid-malignancy patients. Year Published: 2007
Division of Medical Oncology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, Japan. kyonemor@ncc.go.jp
6. Serum total bilirubin as a predictive factor for severe neutropenia in lung cancer patients treated with cisplatin and irinotecan. Year Published: 2007
Division of Internal Medicine and Thoracic Oncology, National Cancer Center Hospital, Tsukiji 5-1-1, Chuo-ku, Tokyo, Japan.
7. Randomised phase III trial of carboplatin plus etoposide vs split doses of cisplatin plus etoposide in elderly or poor-risk patients with extensive disease small-cell lung cancer: JCOG 9702. Year Published: 2007
Department of Respiratory Medicine, Yokohama Municipal Citizen's Hospital, 56 Okazawa-cho, Hodogaya-ku, Yokohama, Kanagawa 240-8555, Japan. scyooka@alles.or.jp
8. Effect of platinum combined with irinotecan or paclitaxel against large cell neuroendocrine carcinoma of the lung. Year Published: 2007
Divisions of Internal Medicine and Thoracic Oncology, National Cancer Center Hospital, Tsukiji 5-1-1, Chuo-ku, Tokyo 104-0045, Japan.
9. Epidermal growth factor receptor mutation detection using high-resolution melting analysis predicts outcomes in patients with advanced non small cell lung cancer treated with gefitinib. Year Published: 2007
Division of Internal Medicine, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan.
10. Prognostic factors for malignant pericardial effusion treated by pericardial drainage in solid-malignancy patients. Year Published: 2007
Division of Medical Oncology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, Japan. kyonemor@ncc.go.jp
11. Epidermal growth factor receptor mutation detection using high-resolution melting analysis predicts outcomes in patients with advanced non small cell lung cancer treated with gefitinib. Year Published: 2007
Division of Internal Medicine, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan.
12. Genetic Variations and Frequencies of Major Haplotypes in SLCO1B1 Encoding the Transporter OATP1B1 in Japanese Subjects: SLCO1B1(*)17 is More Prevalent Than (*)15. Year Published: 2007
Project Team for Pharmacogenetics, National Institute of Health Sciences.
13. Genetic Variations of VDR/NR1I1 Encoding Vitamin D Receptor in a Japanese Population. Year Published: 2007
Project Team for Pharmacogenetics, National Institute of Health Sciences.
14. Genetic variations and frequencies of major haplotypes in SLCO1B1 encoding the transporter OATP1B1 in Japanese subjects: SLCO1B1*17 is more prevalent than *15. Year Published: 2007
Project Team for Pharmacogenetics, National Institute of Health Sciences, Tokyo, Japan.
15. Genetic variations of VDR/NR1I1 encoding vitamin D receptor in a Japanese population. Year Published: 2007
Project Team for Pharmacogenetics, National Institute of Health Sciences, Tokyo, Japan.
16. Genetic variations and frequencies of major haplotypes in SLCO1B1 encoding the transporter OATP1B1 in Japanese subjects: SLCO1B1*17 is more prevalent than *15. Year Published: 2007
Project Team for Pharmacogenetics, National Institute of Health Sciences, Tokyo, Japan.
17. Genetic variations of VDR/NR1I1 encoding vitamin D receptor in a Japanese population. Year Published: 2007
Project Team for Pharmacogenetics, National Institute of Health Sciences, Tokyo, Japan.
18. Phase II trial of preoperative chemoradiotherapy followed by surgical resection in patients with superior sulcus non-small-cell lung cancers: report of Japan Clinical Oncology Group trial 9806. Year Published: 2008
Department of Medical Oncology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan. hkkunito@ncc.go.jp
19. Prognostic factors for malignant pericardial effusion treated by pericardial drainage in solid-malignancy patients. Year Published: 2007
Division of Medical Oncology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, Japan. kyonemor@ncc.go.jp
20. Phase II trial of preoperative chemoradiotherapy followed by surgical resection in patients with superior sulcus non-small-cell lung cancers: report of Japan Clinical Oncology Group trial 9806. Year Published: 2008
Department of Medical Oncology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan. hkkunito@ncc.go.jp
21. Influence of Previous Chemotherapy on the Efficacy of Subsequent Docetaxel Therapy in Advanced Non-small Cell Lung Cancer Patients. Year Published: 2008
Division of Internal Medicine and Thoracic Oncology, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan.
22. Influence of previous chemotherapy on the efficacy of subsequent docetaxel therapy in advanced non-small cell lung cancer patients. Year Published: 2008
Division of Internal Medicine and Thoracic Oncology, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan.